The global women’s health diagnostic testing market is expected to witness an exponential growth over forecast year. The NIH Revitalization Act was formulated in 1993 with a vision to determine the best knowledge about gender and ethnicity differences and similarities and also made women health a national priority. Efforts are now made in order to ensure a healthy lifestyle for women to conform to the laid vision. In terms of healthcare and on a global scale, a high number of women suffer from diseases such as cardiovascular, lung cancer, depression, Alzheimer and urinary contingencies and owing to growth in medical infrastructure across the world and so a higher proportion of women get a timely diagnosis. On the basis of geographic segmentation, the global women’s health diagnostic testing market spans North America, Europe, Middle-East, Asia-Pacific and Africa.
On a commercial basis,
women have distinctive health issues such as menopause, pregnancy and other
minor ailments pertaining to fertility. So, with the rise in number of female
patients for distinct diseases, the market for women’s health and diagnostic
testing market is gaining a positive traction which is likely to augment the
market growth in distant future.
Get Free PDF Sample (Including Full TOC,
List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/womens-health-diagnostic-testing-market/request-sample
The key driving factors
responsible for the growth of women’s health diagnostic testing market include
rising awareness in patients with regards to healthcare concerns, growing
research for detection of several type of cancers and prevention of disease.
Additionally, women’s health diagnostic market also witnesses a significant
growth during the forecast period owing to government initiatives and public
awareness campaigns.
Moreover, the market is
rising due to favorable reimbursement of medical policies and medical coverage
for diagnosis & treatment of disorders. However, factors such as patient’s
unwillingness for early screening which need heavy expenditures for detections,
risk over diagnosis and overtreatment, expensive MRI scans and medicines are
likely to impede the market growth during the forecast period.
On the basis of tests
conducted, the global women’s health diagnostic testing market is segmented
into pregnancy & ovulation, bone density testing, prenatal screening,
mammography, pap smears or cervical cancer screening, colposcopy, HPV testing,
ovarian cancer, urinary tract infections, cystic fibrosis, and autoimmune
diseases. On the basis of prostate cancer screening, the global women’s health
diagnostic testing market is segmented into hospitals, clinics, home
healthcare, research labs, diagnostics and imaging centers and cancer
institutes.
North America leads the
global market owing to advanced healthcare infrastructure, growth in per-capita
income, emphasis on multinational device manufacturing companies and
enhancement of MNC’s. Europe is anticipated to grow during the forecast period
owing to growth in regulations by various medical organizations such as WHO.
Besides, increased funding in public and private sector is propelling the
market growth. APAC regions are anticipated to grow during the forecast period
owing to growth in healthcare scenarios in the regions such as India and China.
The key players in the
global women’s health diagnostic testing market include Nova Biomedical, Quest
Diagnostics Inc., Abbott Laboratories, GE Healthcare, Alere Inc., Hologic,
Inc.,F. Hoffmann-La Roche AG, Becton, PerkinElmer Inc., Dickinson and Company,
bioMérieux SA, Koninklijke Philips N.V, Siemens Healthcare Diagnostics
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment